Cipla Ltd (LUX:CIPLA)
$ 18.1 0 (0%) Market Cap: 14.62 Bil Enterprise Value: 13.65 Bil PE Ratio: 28.74 PB Ratio: 4.53 GF Score: 100/100

Cipla Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 05:10PM GMT
Release Date Price: $11.5 (-0.86%)
Neha Manpuria
JPMorgan Chase & Co, Research Division - Analyst

Hello, and welcome to the JPMorgan Healthcare Conference. I am JPMorgan's India healthcare analyst, Neha Manpuria. It is my pleasure to introduce Mr. Umang Vohra, the CEO and Managing Director of Cipla, who will be taking us through a presentation. Thank you so much for taking time to do this presentation with us, sir. And over to you for the presentation.

Umang Vohra
Cipla Limited - MD, Global CEO & Executive Director

Thank you, Neha, and welcome all of us -- everyone on the call today. I know that these are better times -- that we will have better times where we could meet in person, but I'm happy to take you through the Cipla story over the last 2 to 3 years and what we're looking forward to in the future.

So if you were to go to -- I think, the slide decks are with all of you. I'm just going to call out the first slide is the slide which is about Cipla when it was established. So we're -- just as a quick summary for people who don't know too much about Cipla.

We're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot